Nicola Viebig

Chief Scientific Officer

Nicola joined the European Vaccine Initiative (EVI) in May 2011 as Project Manager. In 2015 she was promoted to Leader Strategic Research, and in June 2018 to Chief Scientific Officer.

Nicola has almost 20 years’ experience in research mainly in the field of infectious diseases, including several years’ experience in vaccine development, research management and pharmaceutical industry (Roche Diagnostics). 

In 2003, Nicola graduated with a Dr. rer. nat. in Biosciences from the Ruprecht-Karls-Universität, Heidelberg, followed by post doc studies at Institut Pasteur, Paris. She is skilled in various laboratory techniques and methods, and has attended numerous and varied courses in recent years. In August 2017, she was awarded with the Project Management Professional (PMP®) certification by the Project Management Institute (PMI).

Apart from her native tongue German, Nicola is fluent in English and French.

Nicola has authored/co-authored ~25 articles, mainly on the clinical development of malaria vaccine candidates and host-pathogen interactions, published in peer reviewed international journals.